These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26420957)

  • 1. Chronic hepatitis C virus infection and lipoprotein metabolism.
    Aizawa Y; Seki N; Nagano T; Abe H
    World J Gastroenterol; 2015 Sep; 21(36):10299-313. PubMed ID: 26420957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus relies on lipoproteins for its life cycle.
    Grassi G; Di Caprio G; Fimia GM; Ippolito G; Tripodi M; Alonzi T
    World J Gastroenterol; 2016 Feb; 22(6):1953-65. PubMed ID: 26877603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.
    Lavie M; Dubuisson J
    Biochimie; 2017 Oct; 141():62-69. PubMed ID: 28630011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Roles of lipoprotein and apolipoprotein in HCV infection].
    Fukuhara T; Matsuura Y
    Uirusu; 2015; 65(2):269-276. PubMed ID: 27760926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
    Blaising J; Pécheur EI
    Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV and host lipids: an intimate connection.
    Schaefer EA; Chung RT
    Semin Liver Dis; 2013 Nov; 33(4):358-68. PubMed ID: 24222093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus.
    Fukuhara T; Ono C; Puig-Basagoiti F; Matsuura Y
    Trends Microbiol; 2015 Oct; 23(10):618-629. PubMed ID: 26433694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and HCV.
    Bassendine MF; Sheridan DA; Bridge SH; Felmlee DJ; Neely RD
    Semin Immunopathol; 2013 Jan; 35(1):87-100. PubMed ID: 23111699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein component associated with hepatitis C virus is essential for virus infectivity.
    Shimizu Y; Hishiki T; Ujino S; Sugiyama K; Funami K; Shimotohno K
    Curr Opin Virol; 2011 Jul; 1(1):19-26. PubMed ID: 22440563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.
    Yang Z; Wang X; Chi X; Zhao F; Guo J; Ma P; Zhong J; Niu J; Pan X; Long G
    J Virol; 2016 Nov; 90(21):9632-9643. PubMed ID: 27535051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
    Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C
    Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.
    Vercauteren K; Mesalam AA; Leroux-Roels G; Meuleman P
    World J Gastroenterol; 2014 Nov; 20(43):15975-91. PubMed ID: 25473151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.
    Pirro M; Bianconi V; Francisci D; Schiaroli E; Bagaglia F; Sahebkar A; Baldelli F
    J Cell Mol Med; 2017 Dec; 21(12):3150-3161. PubMed ID: 28722331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lipid metabolism in hepatitis C virus assembly and entry.
    Popescu CI; Dubuisson J
    Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.
    Crouchet E; Baumert TF; Schuster C
    Expert Rev Proteomics; 2017 Jul; 14(7):593-606. PubMed ID: 28625086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV Interplay with Lipoproteins: Inside or Outside the Cells?
    Cosset FL; Mialon C; Boson B; Granier C; Denolly S
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32290553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of HCV entry into host cells.
    Douam F; Lavillette D; Cosset FL
    Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.
    Calattini S; Fusil F; Mancip J; Dao Thi VL; Granier C; Gadot N; Scoazec JY; Zeisel MB; Baumert TF; Lavillette D; Dreux M; Cosset FL
    J Biol Chem; 2015 Sep; 290(38):23173-87. PubMed ID: 26224633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.